Continental differences in the association between excess body weight and prognosis in triple-negative breast cancer: a meta-analysis
- 30 October 2024
- journal article
- review article
- Published by Springer Nature in Breast Cancer Research and Treatment
- Vol. 209 (2) , 215-227
Abstract
Purpose The association between obesity and triple-negative breast cancer (TNBC) prognosis has been equivocal, with considerable heterogeneity between and within studies. Recent meta-analyses report adverse associations with overall survival (OS) and disease-free survival (DFS) in TNBC. We update this evidence and examine study- and disease-specific sources of heterogeneity. Methods A systematic search of four databases was conducted until February 22, 2023. Random-effects meta-analyses were used to pool hazard ratios (HR) for OS, DFS, and breast cancer-specific mortality (BCSM). Subgroup analyses examined sources of study heterogeneity. Results In meta-analyses of included studies (n = 33), significant associations were observed between excess body weight and worse OS (n = 24; HR = 1.20; 95%CI 1.20–1.34), DFS (n = 26; HR = 1.15; 1.05–1.27), and BCSM (n = 9; HR = 1.13; 1.00–1.27). In subgroup meta-analyses, significant inter-study survival differences were observed for study location (OS, DFS), time period of diagnoses (DFS), menopausal status (OS), and body mass index cut points examined (OS). Asian and European studies reported significant associations with OS (HR = 1.31; 1.11–1.54 and HR = 1.38; 1.00–1.89, respectively) and DFS (HR = 1.28; 1.07–1.54 and HR = 1.44; 1.13–1.84, respectively); however, no association was observed between obesity and TNBC prognosis in North American studies (OS: HR = 1.03; 0.89–1.19; DFS: HR = 1.05; 0.95–1.15). Location subgroup differences remained robust after excluding poor-quality studies. Post hoc analysis in the subset of studies reporting predominantly (≥ 70%) White sample showed no statistically significant associations for OS (HR = 1.13; 95%CI 0.96, 1.34), DFS (HR = 1.03; 95%CI 0.86, 1.23), or BCSM (HR = 1.08; 95%CI 0.91, 1.27). Conclusion This study further confirms that obesity is associated with poor prognosis in TNBC and identified subgroups at higher risk. Ethnic differences in the association between excess body weight and TNBC are reported. Further exploration of study and patient characteristics is needed to properly understand the populations most at risk.Keywords
Funding Information
- Department of Education, Australian Government
- Mater Foundation and Equity Trustees, Australia
- Breast Cancer Research Foundation
This publication has 85 references indexed in Scilit:
- Impact of African ancestry on the relationship between body mass index and survival in an early‐stage breast cancer trial (ECOG‐ACRIN E5103)Cancer, 2022
- Association of Muscle and Adiposity Measured by Computed Tomography With Survival in Patients With Nonmetastatic Breast CancerJAMA Oncology, 2018
- Body mass index, PAM50 subtype, recurrence, and survival among patients with nonmetastatic breast cancerCancer, 2017
- The impact of breast cancer-specific birth cohort effects among younger and older Chinese populationsInternational Journal of Cancer, 2016
- Body mass index and survival after diagnosis of invasive breast cancer: a study based on the Japanese National Clinical Database—Breast Cancer RegistryCancer Medicine, 2016
- Obesity at diagnosis is associated with inferior outcomes in hormone receptor‐positive operable breast cancerCancer, 2012
- Impact of body mass index on clinical outcomes in triple‐negative breast cancerCancer, 2011
- Facilitating meta‐analyses by deriving relative effect and precision estimates for alternative comparisons from a set of estimates presented by exposure level or disease categoryStatistics in Medicine, 2007
- Race, Breast Cancer Subtypes, and Survival in the Carolina Breast Cancer StudyJAMA, 2006
- Advanced methods in meta‐analysis: multivariate approach and meta‐regressionStatistics in Medicine, 2002